Sympathetic nerve activity in essential hypertension. New pathophysiologic aspects;Sympathisches nervensystem und essentielle hypertonie. Neue pathophysiologische aspekte

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 13, 2003, Pages 677-681

  Schlaich, Markus P ^a   Esler, M D ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; NORADRENALIN;

ESSENTIAL HYPERTENSION; NEUROGRAPHY; NEUROMODULATION; PATHOPHYSIOLOGY; REVIEW; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE;

ELECTRODIAGNOSIS; EPINEPHRINE; HUMANS; HYPERTENSION; MICROELECTRODES; NEURONS; NOREPINEPHRINE; SIGNAL PROCESSING, COMPUTER-ASSISTED; SYMPATHETIC NERVOUS SYSTEM;

EID: 0037471020     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38285     Document Type: Review

References (32)

1. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 1989; 14: 177-183
2. Brock JA, Van Helden DF, Dosen P, Rush RA. Prevention of high blood pressure by reducing sympathetic innervation in the spontaneously hypertensive rat. J Auton Nerv Syst 1996; 61: 97-102
3. Brown MJ, Macquin I. Is adrenaline the cause of essential hypertension? Lancet 1981; 2: 1079-1082
4. Chun LL, Patterson PH. Role of nerve growth factor in the development of rat sympathetic neurons in vitro. II. Developmental studies. J Cell Biol 1977; 75: 705-711
5. Clemow DB, Spitsbergen JM, McCarty R, Steers WD, Tuttle JB. Arterial nerve growth factor (NGF) mRNA, protein, and vascular smooth muscle cell NGF secretion in hypertensive and hyperactive rats. Exp Cell Res 1998; 244: 196-205
6. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 1990; 70: 963-985
7. Esler M,Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988; 11: 3-20
8. Esler M, Kaye D, Lambert G, Esler D, Jennings G. Adrenergic nervous system in heart failure. Am J Cardiol 1997; 80: 7L-14L
9. Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P. Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension 1981; 3: 149-156
10. Ferrier C, Jennings GL, Eisenhofer G, Lambert G, Cox HS, Kalff V, Kelly M, Esler MD. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens 1993; 11: 1217-1227
11. Floras JS, Hara K. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension. J Hypertens 1993; 11: 647-655
12. Floras JS. Epinephrine and the genesis of hypertension. Hypertension 1992; 19: 1-18
13. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 1998; 31: 64-67
14. Greenwood JP, Stoker JB, Mary DA. Single-unit sympathetic discharge: quantitative assessment in human hypertensive disease. Circulation 1999; 100: 1305-1310
15. Hagbarth KE, Vallbo AB. Pulse and respiratory grouping of sympathetic impulses in human muscle-nerves. Acta Physiol Scand 1968; 74: 96-108
16. Kaye DM, Vaddadi G, Gruskin SL, Du XJ, Esler MD. Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res 2000; 86: E80
17. Kimura S, Miura Y, Adachi M, Nezu M, Toriyabe S, Sugawara T, Ishizuka Y, Noshiro T, Takahashi M et al. The effect of sodium depletion on plasma norepinephrine kinetics in patients with essential hypertension. Jpn Circ J 1983; 47: 1232-1241
18. Kopf D, Lehnert H. Prädiktive Untersuchungen bei phänotypisch gesunden Nachkommen von Patienten mit einem metabolischen Syndtom. Dtsch Med Wochenschr 2001; 126: 235-240
19. Light KC, Koepke JP, Obrist PA, Willis PWt. Psychological stress induces sodium and fluid retention in men at high risk for hypertension. Science 1983; 220: 429-431
20. Macefield VG, Wallin BG, Vallbo AB. The discharge behaviour of single vasoconstrictor motoneurones in human muscle nerves. J Physiol 1994; 481: 799-809
21. Majewski H, Rand MJ, Tung LH. Activation of prejunctional beta-adrenoceptors in rat atria by adrenaline applied exogenously or released as a co-transmitter. Br J Pharmaco 1981; 73: 669-679
22. Rumantir MS, Jennings GL, Lambert GW, Kaye DM, Seals DR, Esler MD. The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension. J Hypertens 2000; 18: 717-723
23. Rumantir MS, Kaye DM, Jennings GL, Vaz M, Hastings JA, Esler MD. Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension 2000; 36: 824-829
24. Runkel F, Bruss M, Nothen MM, Stober G, Propping P, Bonisch H. Pharmacological properties of naturally occurring variants of the human norepinephrine transporter. Pharmacogenetics 2000; 10: 397-405
25. Schneider MP, Klingbeil AU, Schlaich MP, Langenfeld MR, Veelken R, Schmieder RE. Impaired sodium excretion during mental stress in mild essential hypertension. Hypertension 2001; 37: 923-927
26. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D. Orthostatic intolerance and tachycardia associated with norepinephrine- transporter deficiency. N Engl J Med 2000; 342: 541-549
27. Sherer TB, Neff PS, Hankins GR, Tuttle JB. Mechanisms of increased NGF production in vascular smooth muscle of the spontaneously hypertensive rat. Exp Cell Res 1998; 241: 186-193
28. Stober G, Nothen MM, Porzgen P, Bruss M, Bonisch H, Knapp M, Beckmann H, Propping P. Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 1996; 67: 523-532
29. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, Jennings G. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physio 1992; 453: 45-58
30. Wallin BG, Thompson JM, Jennings GL, Esler MD. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol (Lond) 1996; 491: 881-887
31. Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M. Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension 1989; 13: 870-877
32. Zettler C, Rush RA. Elevated concentrations of nerve growth factor in heart and mesenteric arteries of spontaneously hypertensive rats. Brain Res 1993; 614: 15-20